Navigation Links
Valeant Pharmaceuticals To Host Investor Day
Date:6/7/2012

MONTREAL, June 7, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International (NYSE: VRX) (TSX: VRX) today announced that it will host an Investor Day in Florham Park, New Jersey, on Thursday, June 21, 2012 from 8:30 a.m. to 12:30 p.m. ET.  J. Michael Pearson, Valeant's chairman and chief executive officer, and other members of Valeant's management team will discuss the company's strategies and opportunities in each of its business regions.

A live video webcast and slide presentation of the event will be available on the company's web site at www.valeant.com. To access the webcast select "Investor Relations" and find the event listed under "Events and Presentations."  Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen and view to the Internet webcast. The webcast will be archived on the company's website for future on-demand replay.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
2. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
3. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
4. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
5. Nouveau Life Pharmaceuticals (NOUV) to Begin Sales of Azul Instant™
6. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
7. SOCMAs Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act
8. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
9. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
10. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
11. Isis Pharmaceuticals to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology:
(Date:4/21/2017)... , ... April 21, 2017 , ... Providing broad access ... in opposition, but there is a better way to address this problem. , That ... of Pharmacy, Public Policy and Economics at the University of Southern California, who served ...
(Date:4/21/2017)... ... , ... Brady (NYSE:BRC), a global leader in industrial and safety ... vinyl label materials received certification for the BS5609 British Marine Standard. This internationally ... legible, for use on chemical drums shipped by sea. , “Achieving BS5609 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The VIA Agency , ... for Theravent, Inc. , the makers of a revolutionary new device clinically ... is now working to expand distribution in anticipation of a national launch. VIA ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a home ... of Utah (APCUT) and has appointed Rex Wheeler as its new Director of Business ... our agency and our ability to provide quality care to the community,” said Tammara ...
Breaking Medicine News(10 mins):